Dissemination, Science

A path to therapies: key outstanding questions in dementia research

From the UK DRI

The UK Dementia Research Institute (UKDRI) welcomed researchers and clinicians to a special interest panel discussion and Q&A on key outstanding questions in neurodegenerative disease research, at the recent Federations of Neuroscience Societies (FENS) Conference.

The panellists for the sessions were:

  • Professor Bart De Strooper, UK DRI Director
  • Professor Karen Duff, Centre Director at UK DRI at University College London
  • Professor John Hardy, Group Leader at UK DRI at University College London
  • Professor Giovanna Mallucci, Centre Director at UK DRI at Cambridge University

The session was chaired by UK DRI Director of Scientific Affairs, Dr Giovanna Lalli.

Find out more about the UK DRI at www.ukdri.ac.uk

Leave a Reply


he UK DRI breaks new ground by bringing together world-leading expertise in biomedical, care and translational dementia research in a national institute currently made up of over 600 researchers and a support team of over 50, all growing rapidly.

The institute carries out research relevant to all dementias, including Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia, vascular dementia, Huntington’s disease and beyond.

Translate »